L. T. Hsiao

417 total citations
13 papers, 259 citations indexed

About

L. T. Hsiao is a scholar working on Genetics, Epidemiology and Hematology. According to data from OpenAlex, L. T. Hsiao has authored 13 papers receiving a total of 259 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 5 papers in Epidemiology and 5 papers in Hematology. Recurrent topics in L. T. Hsiao's work include Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Viral-associated cancers and disorders (2 papers). L. T. Hsiao is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Chronic Myeloid Leukemia Treatments (2 papers) and Viral-associated cancers and disorders (2 papers). L. T. Hsiao collaborates with scholars based in Taiwan, Hong Kong and Singapore. L. T. Hsiao's co-authors include Tzeon Jye Chiou, Chih‐Hung Hsu, Han Chong Toh, Pei‐Jer Chen, Chiun Hsu, Ann‐Lii Cheng, Chun‐Yu Liu, Richard J. Epstein, T.-S. Yang and Tai-Jong Chao and has published in prestigious journals such as Journal of Hepatology, British Journal of Cancer and Journal of Hospital Infection.

In The Last Decade

L. T. Hsiao

12 papers receiving 255 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. T. Hsiao Taiwan 7 101 85 79 64 49 13 259
Mari Mandai Japan 8 136 1.3× 111 1.3× 55 0.7× 13 0.2× 8 0.2× 13 294
Augusto Tagliamacco Italy 13 37 0.4× 90 1.1× 97 1.2× 22 0.3× 15 0.3× 20 539
Jérémy Sandrini France 10 94 0.9× 185 2.2× 103 1.3× 58 0.9× 10 0.2× 16 298
Juan Carlos Menéu Díaz Spain 10 153 1.5× 112 1.3× 46 0.6× 20 0.3× 104 2.1× 23 386
Elaine Wong Hong Kong 5 70 0.7× 93 1.1× 64 0.8× 23 0.4× 6 0.1× 7 320
Anne Nihtinen Finland 12 12 0.1× 109 1.3× 102 1.3× 25 0.4× 152 3.1× 24 377
Douglas Thorburn United Kingdom 11 362 3.6× 258 3.0× 107 1.4× 19 0.3× 75 1.5× 20 621
J.F. Castroagudı́n Spain 13 326 3.2× 205 2.4× 78 1.0× 63 1.0× 6 0.1× 37 576
Elizabeth Mroczek United States 7 135 1.3× 73 0.9× 75 0.9× 22 0.3× 28 0.6× 10 361
Hirotaka Tokai Japan 11 80 0.8× 54 0.6× 83 1.1× 21 0.3× 7 0.1× 30 279

Countries citing papers authored by L. T. Hsiao

Since Specialization
Citations

This map shows the geographic impact of L. T. Hsiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. T. Hsiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. T. Hsiao more than expected).

Fields of papers citing papers by L. T. Hsiao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. T. Hsiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. T. Hsiao. The network helps show where L. T. Hsiao may publish in the future.

Co-authorship network of co-authors of L. T. Hsiao

This figure shows the co-authorship network connecting the top 25 collaborators of L. T. Hsiao. A scholar is included among the top collaborators of L. T. Hsiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. T. Hsiao. L. T. Hsiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Chen, Cheng‐Fong, et al.. (2025). Clinical features and surgical treatment of hemophilic pseudotumors: A single-center experience over a 20-year period. Journal of the Chinese Medical Association. 88(10). 774–782.
3.
Hsiao, L. T., et al.. (2014). ABO blood group and the risk of cancer among middle‐aged people in T aiwan. Asia-Pacific Journal of Clinical Oncology. 11(4). e31–6. 17 indexed citations
4.
Lai, Yi‐Chen, Ling Huang, Yufei Yang, et al.. (2012). Impact of Port-A-Cath device management in cancer patients with candidaemia. Journal of Hospital Infection. 82(4). 281–285. 4 indexed citations
6.
Hsu, Chih‐Hung, T.-S. Yang, Chiun Hsu, et al.. (2010). Efficacy and tolerability of bevacizumab plus capecitabine as first-line therapy in patients with advanced hepatocellular carcinoma. British Journal of Cancer. 102(6). 981–986. 105 indexed citations
7.
Chang, Peter Mu‐Hsin, L. T. Hsiao, Jyh-Pyng Gau, et al.. (2010). High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan. Bone Marrow Transplantation. 46(4). 567–572. 31 indexed citations
8.
Liu, Chun‐Yu, Ling Huang, C. C. Yen, et al.. (2009). Candidemia in cancer patients: Impact of early removal of non-tunneled central venous catheters on outcome. Journal of Infection. 58(2). 154–160. 53 indexed citations
9.
Hsiao, L. T., et al.. (2009). Effectiveness of a home-based rehabilitation programme on lower limb functions after stroke.. PubMed. 15(3 Suppl 3). 42–4. 14 indexed citations
10.
Hsiao, L. T., et al.. (2008). HIGH PREVALENCE OF OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH B CELL NON-HODGKINS LYMPHOMA. 87(6). 475–480. 8 indexed citations
11.
Yang, Muh‐Hwa, Liming Bai, L. T. Hsiao, et al.. (2005). Relatively favorable outcomes of post‐transplant pulmonary function in patients with chronic myeloid leukemia receiving non‐myeloablative allogeneic hematopoietic stem cell transplantation. European Journal Of Haematology. 74(2). 152–157. 2 indexed citations
12.
Bai, Liming, Tzeon Jye Chiou, Liu H, et al.. (2003). Hematopoietic stem cell transplantation for severe aplastic anemia—experience of an institute in Taiwan. Annals of Hematology. 83(1). 38–43. 18 indexed citations
13.
Yen, C. C., Liu H, Frank S. Fan, et al.. (2000). Immunophenotypic and genotypic characteristics of chronic myelogenous leukemia in blast crisis.. PubMed. 63(11). 785–91. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026